AFT sees upside from Australian plans to restrict codeine sales

Paul McBeth
Tue, 20 Dec 2016

By Rebecca Howard Dec. 20 (BusinessDesk) – New Zealand’s AFT Pharmaceuticals expects to benefit from news that all medicines containing codeine will be prescription-only in Australia from Feb. 1, 2018. Australia’s medicine’s watchdog, the Therapeutic Goods Administration or TGA, today confirmed products containing codeine will not be able to be sold over the counter in pharmacies. Auckland-based AFT managing director Hartley Atkinson said his company will “undoubtedly” experience a sales increase across the Tasman as a result of the de...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Opinion FREE
Brian Gaynor: a personal obituary
Pattrick Smellie | Mon, 16 May 2022

One of NZ's investment market legends, Brian Gaynor, has died. BusinessDesk managing editor Pattrick Smellie remembers a career-long contact who became a late-career mentor.

Steel & Tube annual operating profit to be up more than 69%
Jenny Ruth | Mon, 16 May 2022

While Steel & Tube's revenue was up 25% in the 10 months ended April on the same months a year earlier, volumes were up just 8%.

Markets FREE
Milford co-founder, BusinessDesk backer Brian Gaynor dies
Staff reporters | Mon, 16 May 2022

One of the greats of the NZ investment world, Brian Gaynor was instrumental in revitalising BusinessDesk.

Grow your business by taking time to plan

Getting business fundamentals right gives the best chance at beating the unplannable.

Partner content
More fuel storage needed now

Boosting fuel reserves could prevent social & economic disruption.